Vesugen is a synthetic short peptide (tripeptide) with a chemical structure composed of three linked amino acids: Lysine, Glutamic Acid, and Aspartic Acid. It belongs to a series of peptide bioregulators developed by Russian scientists and is primarily being investigated for its potential to slow down the aging process and improve associated physiological functions.
Research Status: Current research regarding Vesugen consists primarily of preliminary findings by Russian scientists; given the small sample sizes involved, further large-scale, high-quality studies are required to fully validate its efficacy and safety.
Note: This product is classified as a chemical reagent and is intended solely for scientific research purposes in a laboratory setting. It must not be used on humans or animals, nor employed for any diagnostic, therapeutic, or clinical applications. Furthermore, it is strictly prohibited from being used, either directly or indirectly, in any human trials.